Search

Search Constraints

You searched for: Author/Creator Hegde, Priti

Search Results

1. Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers. Issue 2 (25th November 2020)

2. Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers. Issue 2 (25th November 2020)

3. Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers. Issue 2 (25th November 2020)

4. Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers. Issue 2 (25th November 2020)

5. Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). (4th November 2015)

6. Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Issue 2 (December 2015)

7. Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Issue 1 (December 2016)

9. Profiling Cancer Gene Mutations in Clinical Formalin-Fixed, Paraffin-Embedded Colorectal Tumor Specimens Using Targeted Next-Generation Sequencing. (24th March 2014)

10. Profiling Cancer Gene Mutations in Clinical Formalin‐Fixed, Paraffin‐Embedded Colorectal Tumor Specimens Using Targeted Next‐Generation Sequencing. (24th March 2014)